Vivos Therapeutics Strengthens Leadership for Future Growth

Vivos Therapeutics Expands Management Team

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is proud to announce exciting new leadership changes aimed at driving growth and innovation in the treatment of obstructive sleep apnea (OSA). The company has recently appointed Michael (Mike) E. Bruhn as the Executive Vice President of Business Operations Integration and Dr. Terry Jones as the Senior Vice President of Human Resources.

Commitment to Excellence

These strategic appointments highlight Vivos' dedication to enhancing its new sleep testing center and direct patient treatment operations. This growth initiative is underscored by Vivos' acquisition of The Sleep Center of Nevada and ongoing explorations for similar acquisitions or collaborations aimed at revenue enhancement.

New Leadership Profiles

Mr. Bruhn and Dr. Jones share a profound commitment to the mission of Vivos—eliminating OSA, a common yet underdiagnosed health issue. Under the guidance of R. Kirk Huntsman, Chairman and CEO, both leaders are set to play pivotal roles in the company's transformation.

Strategic Focus of Michael Bruhn

In his new position, Mr. Bruhn will focus on expanding Vivos' reach, particularly in the Eastern United States. His responsibilities include managing the integration of existing and future acquisitions into Vivos' business framework. He aims to foster scalable growth and enhance efficiency, improving access to Vivos' innovative devices for patients battling OSA.

Collaboration with Existing Leaders

Working closely with Susan McCullough, the Executive Vice President of Operations and Co-Founder of Vivos, Mr. Bruhn will oversee all facets of the practical implementation of Vivos' range of OSA treatments in collaboration with dentists and medical professionals.

Impressive Background of Dr. Terry Jones

Dr. Jones brings over two decades of leadership experience from diverse sectors, including federal agencies and international nonprofits. His previous role as Vice President of Human Resources at the USIP showcased his strategic vision and commitment to people-first leadership.

Transformative Human Resource Strategies

As a seasoned HR executive and U.S. Air Force veteran, Dr. Jones is skilled in driving transformative human resources strategies across large organizations. He has previously supported military and civilian personnel in demanding environments, enhancing organizational culture and talent management frameworks along the way.

An Exciting Journey Ahead for Vivos

Mr. Bruhn expressed enthusiasm for joining Vivos at a pivotal moment: "I am excited to leverage my operational expertise in healthcare to support Vivos' growth strategy. My priority will be ensuring that acquisitions, like the Sleep Center of Nevada, are integrated seamlessly into the Vivos ecosystem. This approach will enable us to maximize revenue growth potential as we evolve our strategies."

Further, Dr. Jones articulated his eagerness to shape the company's human resources function by fostering a thriving workplace culture: "It's an honor to be part of Vivos during such significant growth. Collaborating with colleagues to build a supportive environment where every voice is heard is truly inspiring. My goal is to create a workplace that not only values contributions but also enhances employee engagement and satisfaction."

Company Overview

Founded in 2016, Vivos Therapeutics, Inc. is a pioneering medical technology company dedicated to revolutionizing treatment methods for patients suffering from breathing and sleep challenges, especially obstructive sleep apnea (OSA). The company's innovative Complete Airway Repositioning and/or Expansion (CARE) devices are notably the first oral appliances cleared by the U.S. FDA for treating patients with all severity levels of OSA, including severe cases.

Addressing OSA on a Global Scale

With OSA affecting over 1 billion people globally and a staggering 90% unaware of their condition, Vivos is stepping up to tackle this public health crisis. By focusing on sustainable, noninvasive, and innovative solutions, the company aims to empower healthcare providers to better manage the complexities surrounding OSA.

Looking Ahead

With its cutting-edge, nonsurgical oral appliances, Vivos Therapeutics is enabling thousands of patients to regain control over their health and well-being. The continuous development and expansion within this field are just the beginning, and Vivos is set to lead the industry with innovative treatment solutions that matter.

Frequently Asked Questions

What is the primary goal of Vivos Therapeutics?

The primary goal of Vivos Therapeutics is to eliminate obstructive sleep apnea (OSA) through innovative treatment solutions and expanded patient access.

Who is Michael Bruhn?

Michael Bruhn has been appointed as the Executive Vice President of Business Operations Integration at Vivos, focusing on operational growth and integration of acquisitions.

What distinguishes Vivos' CARE devices?

Vivos' Complete Airway Repositioning and/or Expansion (CARE) devices are FDA-cleared for all severity levels of OSA, offering a unique approach to treatment.

How is Dr. Terry Jones contributing to Vivos?

Dr. Terry Jones serves as the Senior Vice President of Human Resources, focusing on building a positive workplace culture and enhancing human resources strategies.

What is Vivos' mission?

The mission of Vivos is to address obstructive sleep apnea effectively, providing innovative solutions that empower both patients and healthcare providers.

About The Author

Riley Hayes here, a financial writer and specialist committed to assisting individuals in navigating the intricate world of finance. My love is using my blog and articles to simplify complex financial ideas into understandable, doable guidance. Having worked in finance for many years, I try to give my readers the information and resources they need to make wise financial choices.

Writing for several financial blogs has let me connect with a wide range of readers, from novice investors seeking new ideas to seasoned investors. My mission is to make money interesting and approachable so you may take charge of your financial future. I appreciate you traveling with me toward success and financial literacy.

Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.